1-Bromo-3-methoxy-5-(trifluoromethyl)benzene, 95.0%, 1g

tert-Butyl 4-[(5-aminopyridin-2-ylamino)methyl]piperidine-1-carboxylate, 95.0%, 1g

(2R,3S,5R)-5-(4-BENZAMIDO-2-OXOPYRIMIDIN-1(2H)-YL)-2-((BENZOYLOXY)METHYL)-4-METHYLENETETRAHYDROFURAN-3-YL BENZOATE, 98%, 25mg

Methyl 2-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate, 95.0%, 1g

2-[5-[(Acryloyloxy)methyl]-5-ethyl-1,3-dioxan-2-yl]-2-methylpropyl Acrylate (cis- and trans- mixture) (stabilized with MEHQ)>95.0%(qNMR)500g

methyl 2-methyl-3-(methylamino)propanoate, 95.0%, 10g

4-Bromo-1-methyl-2-(o-tolyl)-1H-imidazole, 97%, 100mg

Methyl 2-amino-5-(trifluoromethyl)nicotinate, 98+%, 1g

4-Bromo-5-nitroveratrole, 98.0%, 1g

(2,2-Difluorobenzo[d][1,3]dioxol-4-yl)boronic acid, 95.0%, 10g

N,N,N-Trimethyltetradecan-1-aminium chloride, 95.0%, 500g

3-(4-Ethylpiperazin-1-yl)aniline, 98+%, 5g

5-Chlorosalicylanilide>98.0%(T)25g